Hikma Pharmaceuticals USA INC is recalling Alendronate Sodium Oral Solution (70 mg/75 mL), a prescription medication used to treat bone loss. The recall was initiated because certain bottles stored on their side during testing showed out-of-specification assay results, meaning the drug's potency or composition might not meet safety standards. Consumers who have this medication should check their bottles for specific lot numbers and expiration dates to see if their medicine is affected.
The drug may not contain the correct amount of active ingredient due to being stored on its side, which can lead to reduced effectiveness of the treatment for bone loss or other complications. No injuries or incidents have been reported to date.
You have 2 options:
4 x 75 mL Single Dose Bottles per pack. Distributed by Hikma Pharmaceuticals USA Inc., Berkeley Heights, NJ 07922.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.